Key facts
- This page summarizes Robert O Kraft's Form 4 filing for Medpace Holdings, Inc. (MEDP).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Apr 2026, 16:42.
Robert O Kraft - 31 Mar 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)
- Reporting relationship
- Director
- Issuer ticker
- MEDP
- Reported as of
- 31 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Apr 2026, 16:42:14 UTC
- Prior SEC filing
- 10 Mar 2026
- Next SEC filing
- 18 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen P. Ewald, Attorney-in-Fact for Robert O. Kraft
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert O Kraft filed Form 4 for Medpace Holdings, Inc. (MEDP) on 02 Apr 2026.
Change
- Previous filing in this sequence was filed on 10 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001558592
Primary reporting owner
Kraft Robert O.
- Relationship
- Director
- Address
- C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
- Signature
- /s/ Stephen P. Ewald, Attorney-in-Fact for Robert O. Kraft
- Signature date
- 02 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MEDP
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +33
- Change %
- +3.7%
- Price
- Shares after
- 922
- Date
- 31 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MEDP
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -33
- Change %
- -25%
- Price
- $0.000000*
- Shares after
- 97
- Date
- 31 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 33
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
Footnote F2
On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.